Insulin and Biden
8.08pm DC
The Biden administration has announced the first 10 medications that will be subject to price negotiations under Medicare. While it isn't set to take effect until 2026, the White House is "gambling" changes like these can help Biden's reelection chances next year.
Biden pleasantly stunned health care reform advocates Tuesday by including short-acting insulin in its list of 10 drugs for which Medicare will negotiate lower prices, power vested in the White House by the Inflation Reduction Act.
The IRA was passed in the face of one of the heftiest barrages of lobbying in congressional history, with the pharmaceutical industry spending more than $700 million over 2021 and 2022 — several times more than the second- and third-ranking industries — much of it aimed at stopping the legislation, watering it down, or undermining its implementation.
The industry succeeded in narrowing the scope of the new law, with only 10 drugs eligible for negotiation in 2023. But the effort to stop the administration from using that authority to target blockbuster drugs failed spectacularly, as the White House list includes medications that seniors spend billions on in out-of-pocket costs alone, never mind the fees paid by Medicare itself. But it was the inclusion of the broad swath of ingredients and medical devices needed to make insulin that sets the White House move apart and which will likely have the most far-reaching impact.
“This was an unexpected victory in a long fight against an illegal cartel of three corporations who have raised their insulin prices in lockstep,” said Alex Lawson, executive director of Social Security Works, referring to Eli Lilly, Novo Nordisk, and Sanofi. “The inclusion of insulin in the list of negotiated drugs shows that the Biden White House isn’t fucking around.” Lawson’s organization has advocated for drug price negotiations for years, often drawing the ire of the White House and congressional leaders in the process.
Joe Biden’s insulin category covers a wide variety of products, including Fiasp, Fiasp FlexTouch, and Fiasp PenFill — rapid-acting insulin products — as well as commonly prescribed insulin products NovoLog, NovoLog FlexPen, and NovoLog PenFill. Major insulin makers, under severe public pressure, have in recent months announced price cuts to their products, though they could unilaterally raise prices absent this government intervention. “We did not expect to see short-acting insulin on this list. We were caught a little off guard,” said Shaina Kasper, policy and advocacy director for T1International, an organization dedicated to defending the interests of diabetes patients. Broadly speaking, she said it was “the result of years of dogged organizing and advocacy by patients with diabetes and caregivers.”
The IRA laid out specific criteria for which drugs could be included, and the White House went after the 10 that added up to the highest spending among drugs that met that criteria. Kasper said her organization will continue to push for executive action to drive down drug prices — the Biden administration has other authorities it could draw on — as well as legislation at the state and federal level.
Among the 10 drugs are three other treatments for diabetes, including Jardiance, Januvia, and Farxiga. Eliquis and Xarelto, which deal with blood clots, made the list, as did Stelara and Enbrel, which treat psoriasis and psoriatic arthritis. Entresto, prescribed for heart failure, will also come under the Medicare knife. Imbruvica, a blood cancer medication, will similarly be targeted by the government scalpel, news coinciding with House Majority Leader Steve Scalise’s somber announcement that he was diagnosed with a treatable form of blood cancer.
Price negotiations will begin this year and conclude in 2024 but will not go into effect until January 1, 2026. More drugs will be slowly rolled into the program. Next year, the White House will choose 15 more drugs to negotiate, per the IRA, and 15 the year after that. In each subsequent year, 20 new drugs will be added to the list. It is at once the definition of incremental progress, while representing a breakthrough victory against arguably the most powerful special interest in Washington.
Democrats have been campaigning on allowing Medicare to negotiate drug prices since making it a priority in the 2006 midterms — one of then-Democratic Congressional Campaign Committee Chair Rahm Emanuel’s “Six for ‘06” – but traded it away in 2009 to win Big Pharma’s support for the Affordable Care Act. Former President Donald Trump claimed to be a supporter of the policy and negotiated with Democrats on a proposal after the party reclaimed the House in 2018, though no agreement was reached and Trump never implemented any serious executive action on the issue. Biden made it a priority as part of the Build Back Better Act, which became the IRA. The measure’s ability to cut the deficit helped win the support of Joe Manchin, who represents one of the states with the oldest residents in the country, West Virginia.
For those who take a medication that didn’t make the cut, it’s not all bad news, argued Stacie Dusetzina, a health services researcher at Vanderbilt University’s Department of Health Policy. The savings accrued by Medicare from the negotiations will go toward making the Part D drug benefit more generous as early as next year, cutting out-of-pocket costs for many seniors by thousands a year.
=========END————
Thank you, as always, for reading. If you have anything like a spark file, or master thought list (spark file sounds so much cooler), let me know how you use it in the comments below. Thank you so much for letting me vent! If you enjoyed this article, you can give pledge to me same as 25 subscribers (click PLEDGE button) or simply share this article with a friend. It helps me more than you realise.
If you enjoyed this post, please share it.
______________
Professor Hendrik, Professor Eric, and another person, Prof David A. Andelman, former Bureau Chief NYTimes recommended my substack, also some Chief Technology of Financial Times (FT) recommended my substack, not only subscribe. I'd be happy to get more & more PLEDGE and recommendations for better crafted writing (via Bank Central Asia (with my full-name ADI MULIA PRADANA, clearing code 0140119, account number 0201558866 or via STRIPE. For me, prefer Bank Central Asia).
If a friend sent this to you, you could subscribe here 👇. All content is free, and paid subscriptions are voluntary.
——————————————————————————————————
-prada- Adi Mulia Pradana is a Helper. Former adviser (President Indonesia) Jokowi for mapping 2-times election. I used to get paid to catch all these blunders—now I do it for free. Trying to work out what's going on, what happens next. Now figure out and or prevent catastrophic of everything.
(Hopefully more readers more pledges to me, not ended 25 pledges. Thank you so much. My note-live blog about Russia - Ukraine already click-read 6 millions, not counting another note especially Live Update Substack (mostly Live Update Election or massive incident)
=======
Thanks for reading Prada’s Newsletter. I was lured, inspired by someone writer, his post in LinkedIn months ago, “Currently after a routine daily writing newsletter in the last 10 years, my subscriber reaches 100,000. Maybe one of my subscribers is your boss.” After I get followed / subscribed by (literally) prominent AI and prominent Chief Product and Technology of mammoth global media (both: Sir, thank you so much), I try crafting more / better writing.
To get the ones who really appreciate your writing, and now prominent people appreciate my writing, priceless feeling. Prada ungated/no paywall every notes-but thank you for anyone open initiative pledge to me.
(Promoting to more engage in Substack) Seamless to listen to your favorite podcasts on Substack. You can buy a better headset to listen to a podcast here (GST DE352306207).
Listeners on Apple Podcasts, Spotify, Overcast, or Pocket Casts simultaneously. podcasting can transform more of a conversation. Invite listeners to weigh in on episodes directly with you and with each other through discussion threads. At Substack, the process is to build with writers. Podcasts are an amazing feature of the Substack. I wish it had a feature to read the words we have written down without us having to do the speaking. Thanks for reading Prada’s Newsletter.
Wants comfy jogging pants / jogginghose amid scorching summer or (one day) harsh winter like black jogginghose or khaki/beige jogginghose like this? click
Headset and Mic can buy in here, but not including this cat, laptop, and couch / sofa.